# Metsera

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metsera

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.metsera.com/
- Total disclosed funding: $271M
- Latest round: Series B (Nov 12, 2024)
- Investors on record: 17

## About

Based in New York, US, and founded in 2022, Metsera, Inc. is a biopharmaceutical company that develops new treatment strategies for weight loss, weight maintenance, and disease prevention. In September 2025, Pfizer Inc. agreed to fully acquire Metsera, Inc. from Fidelity Investments, Newpath Parners, GV, RA Capital Management and ARCH Venture Partners for USD 65.60 per share, or USD 7 billion in cash. As part of the transaction, Pfizer, Inc. has agreed to pay a contingent value right (CVR) of up to $20.65 per share in potential additional payments subject to Metsera achieving certain milestones.

## Funding rounds

- Series B, Nov 12, 2024, $215M — ARCH Venture Partners, Wellington Management, Viking Global Investors, Fidelity Investments, GV, Alpha Wave Global, RA Capital Management, Janus Henderson Investors, Newpath Partners, Venrock Healthcare Capital Partners, Deep Track Capital, SymBiosis Capital Management, T.Rowe Price Investment Management, Softbank Vision Fund Corporate Development/Ventures
- Series A, Aug 8, 2023, $56M — ARCH Venture Partners, F-Prime Capital, GV, SB Investment Advisers, Mubadala Capital, Newpath Partners

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A
- GV (https://capitalatlas.ai/funds/gv) — Series A, Series B
- SB Investment Advisers (https://capitalatlas.ai/funds/sb-investment-advisers) — Series A
- Mubadala Capital (https://capitalatlas.ai/funds/mubadala-capital) — Series A
- Newpath Partners (https://capitalatlas.ai/funds/newpath-partners) — Series A, Series B
- Wellington Management (https://capitalatlas.ai/funds/wellington-management) — Series B
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series B
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series B
- Alpha Wave Global (https://capitalatlas.ai/funds/alpha-wave-global) — Series B
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series B
- Janus Henderson Investors — Series B
- Venrock Healthcare Capital Partners (https://capitalatlas.ai/funds/venrock-healthcare-capital-partners) — Series B
- Deep Track Capital (https://capitalatlas.ai/funds/deep-track-capital) — Series B
- SymBiosis Capital Management (https://capitalatlas.ai/funds/symbiosis-capital-management) — Series B
- T.Rowe Price Investment Management — Series B
- Softbank Vision Fund Corporate Development/Ventures — Series B